Analysis Tools|
Allele Symbol Allele Name Allele ID |
Tg(Myh6-Ppp3ca)37Eno transgene insertion 37, Eric N Olson MGI:3056186 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary |
14 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• at 3 weeks of age, transgenic mice display a ~2-fold increase in heart weight to tibia length ratio compared to non transgenic mice
|
|
• at 3 weeks of age, transgenic mice display a ~2-fold increase in heart weight to tibia length ratio compared to non transgenic mice
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• Dscr1-deficiency induces a greater increase in cardiac hypertrophy in combination with Tg(Myh6-Ppp3ca)37Eno expression than in wild-type or Dscr1l1-deficiency with transgene expression
|
|
• Dscr1-deficiency induces a greater increase in cardiac hypertrophy in combination with Tg(Myh6-Ppp3ca)37Eno expression than in wild-type or Dscr1l1-deficiency with transgene expression
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• died by 20-28 days of age
|
|
• 110% increase in myocyte size compared to a 34% increase in mice expressing only the transgene
|
|
• showed massive cardiac enlargement that exceeded the hypertrophy induced by the transgene alone
• at 3 weeks of age, 244% increase in heart weight/body weight ratio compared to a 149% increase in mice expressing only the transgene
|
|
• 110% increase in myocyte size compared to a 34% increase in mice expressing only the transgene
|
|
• showed massive cardiac enlargement that exceeded the hypertrophy induced by the transgene alone
• at 3 weeks of age, 244% increase in heart weight/body weight ratio compared to a 149% increase in mice expressing only the transgene
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• cardiac hypertrophy due to hypertrophy of individual cardiomyocytes
|
|
• cardiac mass increases by 220% as opposed to 110% for controls
|
|
• cardiac hypertrophy due to hypertrophy of individual cardiomyocytes
|
|
• cardiac mass increases by 220% as opposed to 110% for controls
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• transgenic mice are highly susceptible to sudden death from heart failure with none surviving beyond 8 weeks of age
|
|
• by 4 weeks of age mutant hearts are 3-fold larger than wild-type due to hypertrophy
|
|
• by 4 weeks of age mutant hearts are 3-fold larger than wild-type due to hypertrophy
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• hypertrophy induced by the transgene was reduced
|
|
• hypertrophy induced by the transgene was reduced
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• myofibrillar hypertrophy
|
|
• identical to control mice with the transgene alone
• three fold increase in heart/body weight ratio
• wall thickening
|
|
• myofibrillar hypertrophy
|
|
• identical to control mice with the transgene alone
• three fold increase in heart/body weight ratio
• wall thickening
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• dramatic cardiac hypertrophy as indicated by an increase in heart weight to body weight ratio at 1 month of age that is similar to single Tg(Myh6-Ppp3ca)37Eno mice
|
|
• thickening of the left ventricle free wall and septum are decreased compared to single Tg(Myh6-Ppp3ca)37Eno mice
|
|
• mice show an increase in cardiac fibrosis compared to single Tg(Myh6-Ppp3ca)37Eno mice
|
|
• dramatic cardiac hypertrophy as indicated by an increase in heart weight to body weight ratio at 1 month of age that is similar to single Tg(Myh6-Ppp3ca)37Eno mice
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• half die by 10 weeks of age and all die by 18 weeks of age
• die earlier than mice carrying Tg(Myh6-Ppp3ca)37Eno alone
• appear to die from heart failure
|
|
• decrease in left ventricular wall thickness
|
|
• increase in left ventricular dimension and decrease in wall thickness
|
|
• fractional shortening is around 10%
|
|
• fractional shortening is around 10%
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• null mice expressing the transgene do not show cardiomyocyte hypertrophy or fibrosis in with expression of this transgene, in contrast to wild-type transgenic mice
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice show large atrial clots
|
|
• cardiac hypertrophy is not enhanced above that observed in Tg(Myh6-Mef2c)2Jmol single transgenic animals
|
|
• degree of functional decompensation is not enhanced compared to Tg(Myh6-Mef2c)2Jmol single transgenic mice
|
|
• degree of functional decompensation is not enhanced compared to Tg(Myh6-Mef2c)2Jmol single transgenic mice
|
|
• cardiac hypertrophy is not enhanced above that observed in Tg(Myh6-Mef2c)2Jmol single transgenic animals
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• cardiac hypertrophy is not enhanced above that observed in Tg(Myh6-MEF2A)1Jmol single transgenic animals
|
|
• cardiac hypertrophy is not enhanced above that observed in Tg(Myh6-MEF2A)1Jmol single transgenic animals
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• about 50% survive to 20 weeks of age
|
|
• hypertrophy is attenuated in mice treated with an adeno-virus expressing Mlip as neonates
|
|
• hypertrophy is attenuated in mice treated with an adeno-virus expressing Mlip as neonates
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• transgenic mice are highly susceptible to sudden death from heart failure
|
|
• at 3 weeks of age, transgenic mice display a ~2-fold increase in heart weight to tibia length ratio
(J:109586)
|
|
• the heart to body weight ratio is increased 2-3 fold as early as P18 with concentric hypertrophy seen, both ventricles and atria are affected
(J:93176)
• cyclosporin A treatment prevented hypertrophy and fibrosis
(J:93176)
• at 3 weeks of age, showed a 149% increase in heart weight/body weight ratio compared to wild-type
(J:94665)
|
|
• 34% increase in myocyte area compared to wild-type
|
|
• the ventricular cardiomyocytes are disorganized, hypertrophic and display enlarged nuclei
|
|
• at 3 weeks of age, transgenic mice display a ~2-fold increase in heart weight to tibia length ratio
(J:109586)
|
|
• the heart to body weight ratio is increased 2-3 fold as early as P18 with concentric hypertrophy seen, both ventricles and atria are affected
(J:93176)
• cyclosporin A treatment prevented hypertrophy and fibrosis
(J:93176)
• at 3 weeks of age, showed a 149% increase in heart weight/body weight ratio compared to wild-type
(J:94665)
|
|
• dilation of the ventricles is seen in older transgenic mice
|
|
• dilation of the ventricles is seen in older transgenic mice
|
|
• extensive, primarily interstitial fibrosis is seen in the ventricular walls sometimes associated with myofiber degeneration
|
|
• perivascular edema in the lungs is seen in transgenic mice that die suddenly
|
|
• perivascular edema in the lungs is seen in transgenic mice that die suddenly
|
|
• 34% increase in myocyte area compared to wild-type
|
|
• the ventricular cardiomyocytes are disorganized, hypertrophic and display enlarged nuclei
|
|
• extensive, primarily interstitial fibrosis is seen in the ventricular walls sometimes associated with myofiber degeneration
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:93176 | |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|
|
||
